Please visit if you are unable to view this page properly.

July 5, 2012

For Immediate Release


Nano Today Leaps in Impact Factor Ranking
Consolidates Standing as the Second Most Influential
Nanoscience and Nanotechnology Journal Globally

Singapore, July 5, 2012 – With a significant increase in impact factor of 31% from 11.750 to 15.355, Nano Today is now ranked #2 out of 66 journals in Nanoscience and Nanotechnology, according to the latest Journal Citation Reports® published by Thomson Reuters in June 2012.

In addition, the journal ranked #4 out of 231 journals in Materials Science (Multidisciplinary), and #5 out of 152 journals in Chemistry (Multidisciplinary), consolidating its position as a leading journal that serves a broad readership. Nano Today is also the only Asia-based journal among the top 5 journals in each list.

“We are both excited and happy about the new impact factor of Nano Today. I would like to thank the readers, authors, referees, editorial advisory board, as well as our Managing Editor, Noreena AbuBakar, for all their contributions and support. Nanotechnology is a rapidly advancing field that holds great potential to benefit society through the creation of new materials or devices. The journal will continue to publish the latest and most exciting developments in this multidisciplinary field,” shared Professor Jackie Y. Ying, Editor-in-Chief of Nano Today, who is also the Executive Director of the Institute of Bioengineering and Nanotechnology, Singapore, the world's first bioengineering and nanotechnology research institute.

The Journal Citation Reports® are the recognized authority for evaluating journals, presenting quantitative data that supports a systematic and objective review of the world's leading journals, as well as measures their impact and influence in the global research community.

Nano Today is an international, peer-reviewed journal for researchers with interests across the whole spectrum of nanoscience and nanotechnology. Through review articles, rapid communications, news and opinions, it features the latest breakthroughs in nanoscience, and the impacts of nanotechnology on biomedical, electronic, chemical and energy applications.

Since successfully transitioning from a magazine to a journal format in 2009 under the leadership of Professor Ying, Nano Today has recorded major increases in the Impact Factor from 5.929 in 2007 to 15.355 in 2011. The excellent impact factor rating achieved by Nano Today in such a short span of time is an indicator of the quality and influence the journal has garnered within the international research community.

Nano Today is one of the best journals in its field because it puts quality and engagement at the heart of what it does. This result shows two things. First, that Nano Today is truly one of the best publications in the world for any serious researcher who wants to be published in a leading title. Second, and most importantly, it reflects the tireless dedication and vision of Jackie and her team in actively commissioning the very best that this area of science has to give for the benefit of scientists around the world. All of us at Elsevier feel proud to work with Jackie on this exciting journal,” said Deborah Logan, Publishing Director, Materials Science Journals, Elsevier.

The Elsevier journal is organizing the 3rd Nano Today Conference with the Institute of Bioengineering and Nanotechnology. The conference will be held in Biopolis, Singapore on December 8-11, 2013 ( The bi-annual Nano Today conference series that started in 2009 has now become a major forum for the exchange of ideas and latest findings in nanoscience and nanotechnology. The last conference was held in Hawaii in December 2011 with 500 participants, and the inaugural conference was held in Singapore in August 2009 with 450 participants.

For the latest information visit:

For queries about Nano Today and Elsevier, contact:

Deborah Logan
Publishing Director, Materials Science Journals
DID: 44 1865 843061
BB: 44 7789 921235

Tanja Leijs
Marketing Communications Manager

For queries about IBN and interview requests with Professor Jackie Y. Ying, contact:

Elena Tan
Institute of Bioengineering and Nanotechnology
DID: 65 6824 7032

Nidyah Sani
Institute of Bioengineering and Nanotechnology
DID: 65 6824 7005

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Nano Today

Nano Today provides a peer-reviewed forum for the publication of authoritative review articles, rapid communications, and news and opinions that shape and define the frontiers of nanoscience and nanotechnology through their multidisciplinary applications (see attached flyer). It publishes six issues per year covering all aspects of nanoscience and nanotechnology.

  • Synthesis and Self-Assembly of Nanostructured Materials and Films
  • Functionalization and Size-Dependent Properties of Nanocrystals, Quantum Dots and Nanowires
  • Processing and Templating of Nanotubes and Nanoporous Materials
  • Tailoring of Polymeric Nanoparticles, Organic-Inorganic Nanocomposites and Biohybrids
  • Fabrication of Nano and Micro Electro Mechanical Systems
  • Design and Engineering of Structural and Functional Nanomaterials
  • Nanosystems for Biological, Medical, Chemical, Catalytic, Energy and Environmental Applications
  • Nanodevices for Electronic, Photonic, Magnetic, Imaging, Diagnostic and Sensor Applications

For more information, please visit

For more information on the 3rd Nano Today Conference, please visit

About the Institute of Bioengineering and Nanotechnology

The Institute of Bioengineering and Nanotechnology (IBN) was established in 2003 and is spearheaded by its Executive Director, Professor Jackie Yi-Ru Ying, who has been on the Massachusetts Institute of Technology's Chemical Engineering faculty since 1992, and was among the youngest to be promoted to Professor in 2001.

In 2008, Professor Ying was recognized as one of “One Hundred Engineers of the Modern Era” by the American Institute of Chemical Engineers for her groundbreaking work on nanostructured systems, nanoporous materials and host matrices for quantum dots and wires.

Under her direction, IBN conducts research at the cutting-edge of bioengineering and nanotechnology. Its programs are geared towards linking multiple disciplines across engineering, science and medicine to produce research breakthroughs that will improve healthcare and our quality of life.

IBN's research activities are focused in the following areas:

  • Drug and Gene Delivery, where the controlled release of therapeutics involve the use of functionalized polymers, hydrogels and biologics for targeting diseased cells and organs, and for responding to specific biological stimuli.

  • Cell and Tissue Engineering, where biomimicking materials, stem cell technology, microfluidic systems and bioimaging tools are combined to develop novel approaches to regenerative medicine and artificial organs.

  • Biodevices and Diagnostics, which involve nanotechnology and microfabricated platforms for high-throughput biomarker and drug screening, automated biologics synthesis, and rapid disease diagnosis.

  • Pharmaceuticals Synthesis and Green Chemistry, which encompasses the efficient catalytic synthesis of chiral pharmaceuticals, and new nanocomposite materials for sustainable technology and alternative energy generation.

IBN’s innovative research is aimed at creating new knowledge and intellectual properties in the emerging fields of bioengineering and nanotechnology to attract top-notch researchers and business partners to Singapore. Since 2003, IBN researchers have published over 769 papers in leading journals.

IBN also plays an active role in technology transfer and spinning off companies, linking the research institute and industrial partners to other global institutions. The Institute has a portfolio of over 695 patents/patent applications on its inventions, and welcomes industrial and clinical partners to collaborate on and co-develop its technologies. IBN has successfully commercialized 33 patents/patent applications.

IBN’s current staff and students strength stands at over 150 scientists, engineers and medical doctors. With its multinational and multidisciplinary research staff, the Institute is geared towards generating new biomaterials, devices, systems and processes to boost Singapore's economy in the medical technology, pharmaceuticals, chemicals, consumer products and clean technology sectors.

IBN is also committed to nurturing young talents. Besides the training of PhD students, IBN has a Youth Research Program (YRP) for students and teachers from secondary schools, junior colleges, polytechnics, and universities. Since its inception in October 2003, IBN’s YRP has reached out to more than 55,600 students and teachers from 286 local and overseas schools and institutions. Over 1,600 students and teachers have completed research attachments at IBN for a minimum period of four weeks.

For more information, please visit